Doctor-Patient Communication in Spanish

Hypertension Clinical Trial

Official title:

Doctor-Patient Communication in Spanish

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00187785
• Other study ID #: UMC200552
• Status: Terminated
• Phase: N/A
• First received: September 14, 2005
• Last updated: January 13, 2006
• Start date: September 2005
• Est. completion date: December 2006

Study information

• Verified date: August 2005
• Source: University of California, San Francisco
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Does use of a translator or use of less than perfect Spanish diminish provider-patient communication compared to a native speaker.

Description:

Spanish speaking drop-in patients will be consented then randomized to receive care by a native Spanish speaker, an English speaker using a translator, or an English speaker with intermediate Spanish skills using Spanish. After the visit, the researcher will enquire about patient satisfaction, when the next appointment is, whether medication has been changed, and what instructions their provider gave them. Each provider will do a similar questionnaire. A blinded researcher will score a concordance of plans between provider and patient to see if there is a significant difference in retained information between the groups.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 100
• Est. completion date: December 2006
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Spanish speaker

Exclusion Criteria:

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Educational/Counseling/Training

Related Conditions & MeSH terms

• Diabetes
• Hypertension
• Respiratory Tract Infections
• Upper Respiratory Infection

Intervention

Behavioral:
• Spanish speaker level

Locations

Country	Name	City	State
United States	UMC Family Health Center	Fresno	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, San Francisco

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	retention of medical information
Secondary	patient satisfaction